DAVID E. JORDEN FOR CYTOMEDIX, INC.

Company

Nuo Therapeutics, Inc.

Filed

January 6, 2005

Accession Number

0000950129-05-000128

A Schedule 13D is filed when an investor acquires more than 5% of a company's shares with an intent to influence control. Learn more about SC 13D filings →